Connect Non-Clinical Solutions
ERBC Group is a 50 years’ leading CRO committed to bridge the gap between preclinical and clinical research by better predicting the efficacy and safety of new compounds offering innovative in vitro and in vivo translational models and services.
Offering a comprehensive range of experimental capabilities, preclinical models, regulatory pre-IND package and consultancy services, ERBC allows biopharmaceutical and chemical industry professionals to de-risk innovation and enhance R&D productivity.
With highly qualified teams, ERBC Group is offering a customer-centric approach while committed in improving all aspects of study design and conduct applying alternatives to animal testing as a priority.
CRO, Pharmacology, Safety Pharmacology, Toxicology, Bioanalysis, Cardiology, Neurology, Pneumology, Oncology, Immuno-oncology, Allergy, Dermatology, Gastro-enterology, Analgesia/inflammation, Endocrinology, Haematology, Nephrology, Chemistry, AAALAC, and GLP
The Non-Clinical Engine: European leader in non-clinical studies
Stemming from the merger of two reference CROs in pharmacology and toxicology (CERB and RTC), European Research Biology Center (ERBC) is a European leader in non-clinical studies.
It offers to healthcare and chemical professionals a comprehensive range of experimental capabilities, preclinical models, regulatory pre-IND package and consultancy services to de-risk innovation and improve R&D productivity.
Based in Baugy (France) and Roma (Italy), ERBC provides all services from preclinical proof-of-concept to market of any type of drug candidate or chemical compound. Each project is managed by a study director, relying on a multi-disciplinary team of experts, notably in general pharmacology, cardiology, electrophysiology and pathophysiology, also benefiting from a world class academic and private network.
Every year, study reports from our two Centers are successfully used in support of market authorization and new product approval submissions around the world, including the European (EMA, ECHA), US (FDA and EPA) and Japanese (MHLW and MAFF) regulatory authorities.
Investment in outstanding scientific and technical manpower, high-tech equipment and facilities are crucial cornerstones of our sound and organic growth. The quality and reliability of our performance is reflected by the many ongoing and long-lasting collaborations we maintain with leading international pharmaceutical and chemical companies.
ERBC is deeply engaged in animal ethics and welfare. ERBC supports the Basel Declaration, respects the 3Rs concept and continually improves its tools and procedures to maximize the balance between the benefit for health and the animal well-being.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 25 Jun 2024 | | |
Pôle de compétitivité DERBI Public business cluster, French Cluster, IT Services and IT Consulting | Pôle de compétitivité DERBI Public business cluster, French Cluster, IT Services and IT Consulting | Other 25 Jun 2024 | | |
Agri Sud-Ouest Innovation Public business cluster, French Cluster, Food and Beverage Manufacturing | Agri Sud-Ouest Innovation Public business cluster, French Cluster, Food and Beverage Manufacturing | Other 25 Jun 2024 | | |
AQUA-VALLEY Public business cluster, Non-profit Organizations | AQUA-VALLEY Public business cluster, Non-profit Organizations | Other 25 Jun 2024 | | |
Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Other 20 May 2024 | | |
PULSALYS Research, Research Services | PULSALYS Research, Research Services | Other 27 Jan 2023 | | |
Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 8 Oct 2024 | | |
Région Auvergne-Rhône-Alpes National and local authorities, Government Administration | Région Auvergne-Rhône-Alpes National and local authorities, Government Administration | Other 29 Nov 2023 | | |
Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 13 Dec 2023 | |